| Dr Robert Anthony Armbruster, MD | |
|
3550 Mckelvey Rd, Bridgeton, MO 63044-2527 | |
| (314) 741-0911 | |
| (314) 741-0501 |
| Full Name | Dr Robert Anthony Armbruster |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 18 Years |
| Location | 3550 Mckelvey Rd, Bridgeton, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174728893 | NPI | - | NPPES |
| 500849396 | Medicaid | IL |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Des Peres Hospital | Saint louis, MO | Hospital |
| Missouri Baptist Medical Center | Town and country, MO | Hospital |
| Christian Hospital Northeast | Saint louis, MO | Hospital |
| Parkland Health Center | Farmington, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Louis Heart And Vascular Pc | 7719880129 | 22 |
| St Louis Heart And Vascular Pc | 7719880129 | 22 |
News Archive
Women who started menstruating early in life could later face a higher risk of stroke.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Consumer Watchdog called on the Obama Administration to adopt new regulations requiring broad financial disclosures by health insurance companies to help insulate Americans from double-digit rate increases. Insurers should provide details of shadowy multibillion-dollar transfers to out-of-state affiliates and parent companies when they are required to justify "unreasonable" rate increases under the health reform law, said the group.
Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore.
New research published Online First in The Lancet suggests that increasing the duration of resuscitation efforts could improve survival in patients who arrest in hospital, challenging the common belief that extending resuscitation in patients who do not respond immediately is often futile.
› Verified 9 days ago
| Entity Name | St Louis Heart & Vascular Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487678165 PECOS PAC ID: 7719880129 Enrollment ID: O20040131000106 |
News Archive
Women who started menstruating early in life could later face a higher risk of stroke.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Consumer Watchdog called on the Obama Administration to adopt new regulations requiring broad financial disclosures by health insurance companies to help insulate Americans from double-digit rate increases. Insurers should provide details of shadowy multibillion-dollar transfers to out-of-state affiliates and parent companies when they are required to justify "unreasonable" rate increases under the health reform law, said the group.
Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore.
New research published Online First in The Lancet suggests that increasing the duration of resuscitation efforts could improve survival in patients who arrest in hospital, challenging the common belief that extending resuscitation in patients who do not respond immediately is often futile.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Anthony Armbruster, MD 3550 Mckelvey Rd, Bridgeton, MO 63044-2527 Ph: (314) 741-0911 | Dr Robert Anthony Armbruster, MD 3550 Mckelvey Rd, Bridgeton, MO 63044-2527 Ph: (314) 741-0911 |
News Archive
Women who started menstruating early in life could later face a higher risk of stroke.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Consumer Watchdog called on the Obama Administration to adopt new regulations requiring broad financial disclosures by health insurance companies to help insulate Americans from double-digit rate increases. Insurers should provide details of shadowy multibillion-dollar transfers to out-of-state affiliates and parent companies when they are required to justify "unreasonable" rate increases under the health reform law, said the group.
Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore.
New research published Online First in The Lancet suggests that increasing the duration of resuscitation efforts could improve survival in patients who arrest in hospital, challenging the common belief that extending resuscitation in patients who do not respond immediately is often futile.
› Verified 9 days ago
Robert M Fischer, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12303 De Paul Dr, Radiology Dept, Bridgeton, MO 63044 Phone: 314-770-9393 Fax: 314-770-9997 | |
Dr. Ashfaq Ullah, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 12255 De Paul Dr Ste 500, Bridgeton, MO 63044 Phone: 314-209-5180 | |
Sean T Mclaughlin, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr, Suite 504, Bridgeton, MO 63044 Phone: 314-298-3893 Fax: 314-851-4408 | |
Dr. Raymond Frederick Mohrman Jr., MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 12266 De Paul Dr Ste 300, Bridgeton, MO 63044 Phone: 314-291-8824 | |
Navid S Siddiqui, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr Ste 600, Bridgeton, MO 63044 Phone: 314-209-5100 | |
Robert Byrne, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr, Suite 700, Bridgeton, MO 63044 Phone: 314-739-4166 Fax: 314-739-2485 | |
Melvin Boris Saltzman, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr, Ste 404, Bridgeton, MO 63044 Phone: 314-770-1000 Fax: 314-770-2456 |